Correction: Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas

Correction: Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas

Saved in:

Bibliographic Details
Main Authors:	Jinpeng Li, Yuanming Li, Jingtao Zhong, Jiasheng Du, Jiao Chen, Jutian Shi, Lujun Zhao, Jinlong Song
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Immunology
Subjects:	hepatocellular carcinoma high-flow hepatic arteriovenous fistula hepatic arterial infusion chemotherapy immune checkpoint inhibitors tyrosine kinase inhibitors
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1681008/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas
by: Jinpeng Li, et al.
Published: (2025-08-01)

Efficacy and safety of TACE-HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for the patients with BCLC-defined stage B-C HCC
by: Bowen Liu, et al.
Published: (2025-07-01)

Case Report: Congenital hepatic hemangioma with arteriovenous fistula: 2-year multidisciplinary management and outcomes
by: Renping Mao, et al.
Published: (2025-04-01)

PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy
by: Fei Cao, et al.
Published: (2025-06-01)

Histopathologic deep learning model for predicting tumor response to hepatic arterial infusion chemotherapy plus TKIs and ICIs in large hepatocellular carcinoma
by: Chunyu Lin, et al.
Published: (2025-06-01)

Transarterial intervention therapy plus systemic therapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
by: Zelong Liu, et al.
Published: (2025-09-01)

HBV reactivation and prognosis after systemic therapy in HCC with undetectable HBV DNA: a multicenter retrospective study
by: Zhipeng Liang, et al.
Published: (2025-08-01)

RALOX-HAIC (raltitrexed + oxaliplatin) combined with lenvatinib improves survival and safety in elderly patients with unresectable hepatocellular carcinoma
by: Haohao Lu, et al.
Published: (2025-05-01)

Atypical Cystic Primary Hepatic GIST: A Case Report of Rare Presentation and Long-Term Survival
by: Mirela Claudia Rimbu, et al.
Published: (2025-07-01)

Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinoma
by: Haohao Lu, et al.
Published: (2024-11-01)

Imaging Diagnosis of Neonatal Umbilical Arteriovenous Malformation Complicated with Portosystemic Shunt
by: Zhang Minyu, Jia Baocheng, Huang Liuming
Published: (2025-06-01)

Hepatic arterial infusion chemotherapy (HAIC) plus Lenvatinib and PD-1 inhibitors versus systemic chemotherapy for unresectable intrahepatic cholangiocarcinoma
by: Qingyu Xu, et al.
Published: (2025-05-01)

Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study)Research in context
by: Wei Gao, et al.
Published: (2025-05-01)

Efficacy and safety of TACE combined with TKIs and PD-1 inhibitors in HCC patients with prior TIPS
by: Kai Xiong, et al.
Published: (2025-04-01)

Commentary: Case Report: Congenital hepatic hemangioma with arteriovenous fistula: 2-year multidisciplinary management and outcomes
by: Huaijie Wang, et al.
Published: (2025-07-01)

Clinical application of autogenous arteriovenous fistula restriction in high flow arteriovenous fistula
by: Chen Ru-man, et al.
Published: (2022-01-01)

Early Prediction of Native Arteriovenous Fistula for Maturation by Doppler Ultrasound Study
by: Shivali Gupta, et al.
Published: (2024-10-01)

Hepatic failure at obstructive parasitogenic cholestasis
by: V. F. Tskhay, et al.
Published: (2004-06-01)

Hepatic artery infusion chemotherapy plus an immune checkpoint inhibitor and lenvatinib for the treatment of biliary tract carcinoma
by: Junying Wang, et al.
Published: (2025-06-01)

Successful splenic arteriovenous shunt embolization for hepatic encephalopathy associated with splenic arteriovenous shunt and intrahepatic portosystemic venous shunt
by: Kiichiro Ishikawa, MD, et al.
Published: (2025-11-01)

Experience of Hepatocellular Cancer Therapy with Multikinase Inhibitors in the Republic of Bashkortostan
by: Sh. Kh. Gantsev, et al.
Published: (2020-11-01)

An arteriovenous fistula following chalazion excision
by: Dias-Amborcar Yuri, et al.
Published: (2007-01-01)

Arteriovenous Fistula Pseudoaneurysm Mimicking Cutaneous a Neoplasm Arising from a Stenosed Arteriovenous Fistula
by: Hayato Hanada, et al.
Published: (2025-01-01)

Percutaneous transhepatic arterial access for coil embolization of hepatic artery infusion pump-associated bleeding
by: Anuj K. Dutta, et al.
Published: (2025-01-01)

Effect of cognitive level on mastery of knowledge on arteriovenous fistula maintenance in maintenance hemodialysis patients
by: FENG Lei, et al.
Published: (2019-01-01)

The Role of Plant-Derived Natural Products as a Regulator of the Tyrosine Kinase Pathway in the Management of Lung Cancer
by: Faris Alrumaihi, et al.
Published: (2025-06-01)

Rheolytic Pharmacomechanical Thrombectomy in Renal Dialysis Arteriovenous Fistula and Graft Thrombosis: Outcomes from a Tertiary Hospital in Qatar
by: Ahmad L. F. Yasin, et al.
Published: (2025-01-01)

Community characteristics and relationship between gut microbiota and intratumoral microbiota in hepatocellular carcinoma
by: Huangpeng Lin, et al.
Published: (2025-01-01)

Coexisting pseudoaneurysm and arteriovenous fistula following percutaneous nephrolithotomy
by: Pankaj Kanti Dey, et al.
Published: (2023-05-01)

Knowledge of the patients in treatment of hemodialise about arteriovenous fistula
by: Angelina Monteiro Furtado, et al.
Published: (2006-06-01)

Survival outcomes after surgical resection of huge HCC (≥ 10 cm) with or without neoadjuvant hepatic arterial infusion chemotherapy
by: Chia-Ling Chiang, et al.
Published: (2025-06-01)

PD(L)1 Inhibitors Plus Lenvatinib Vs Atezolizumab Plus Bevacizumab Combined With HAIC for Unresectable HCC: A Propensity Score Matching Study
by: He Z, et al.
Published: (2025-01-01)

An investigation of the Effect of Antihypertensive drugs on Arteriovenous Fistula Maturation in Patients with Hemodialysis
by: Fatemeh Mahmoudlou, et al.
Published: (2025-06-01)

Advancing endometrial cancer treatment: exploring immunotherapy and tyrosine kinase inhibitors through clinical cases
by: Vanda Salutari
Published: (2025-06-01)

Optimization of the surgical arteriovenous fistula for end-stage renal disease
by: David B. Kingsmore, MD, FRCS, Mb ChB, BMEdBiol, et al.
Published: (2025-01-01)

Research progress on the application of antiplatelet drugs in arteriovenous fistula for hemodialysis
by: Ma Shi-jie, et al.
Published: (2025-07-01)

Clinical effects of high arteriovenous fistula with different anastomotic diameters
by: LIN Ye, et al.
Published: (2018-01-01)

Spontaneous arteriovenous fistula of the splenic pedicle with isolated heart failure: A case report and litterature review
by: Antoine Mathivet, et al.
Published: (2024-12-01)

Clinical research of arteriovenous fistula as an initial vascular access
by: Shi You-shan, et al.
Published: (2022-06-01)

Treating intracranial dural arteriovenous fistulas with gamma knife radiosurgery: A single-center experience
by: Guan-Chyuan Wang, et al.
Published: (2017-01-01)